Literature DB >> 33632337

Expression analysis of tissue factor pathway inhibitors TFPI-1 and TFPI-2 in Paralichthys olivaceus and antibacterial and anticancer activity of derived peptides.

Guanghua Wang1, Bing Xie1, Yanli Su1, Qinqin Gu1, Dongfang Hao1, Hongmei Liu1, Changbiao Wang1, Yonghua Hu2,3,4, Min Zhang5,6.   

Abstract

Tissue factor pathway inhibitors (TFPI), including TFPI-1 and TFPI-2, are Kunitz-type serine protease inhibitors that mainly inhibit the blood coagulation induced by tissue factors. Previous reports on teleost proved TFPI play important roles in innate immunity. In this study, two TFPI (PoTFPI-1 and PoTFPI-2) molecules from Japanese flounder (Paralichthys olivaceus) were analyzed and characterized for their expression patterns, antibacterial and anticancer activities of the C-terminal derived peptides. Quantitative real time RT-PCR analysis shows that constitutive PoTFPI-1 expression occurred, in increasing order, in the brain, muscle, spleen, gills, head kidney, blood, intestine, heart, and liver; PoTFPI-2 was expressed, in increasing order, in the brain, gills, head kidney, muscle, intestine, spleen, liver, heart, and blood. Under the stimulation of fish pathogens, both PoTFPI-1 and PoTFPI-2 expressions increased significantly in a manner that depended on the pathogens, tissue type, and infection stage. Furthermore, C-terminal peptides TP25 and TP26, derived from PoTFPI-1 and PoTFPI-2, respectively, were synthesized and proved to be active against Micrococcus luteus (for TP25 and TP26) and Staphylococcus aureus (for TP25) via retardation effects on bacterial nucleic acids. In addition, TP25 and TP26 also displayed significant inhibitory effects on human colon cancer cell line HT-29. These results reveal that both PoTFPI-1 and PoTFPI-2 play important roles in host innate immunity. The antibacterial activity and anticancer cells function of TP25 and TP26 will add new insights into the roles of teleost TFPI.

Entities:  

Keywords:  Antibacterial activity; Anticancer cell activity; C-terminal peptides; Paralichthys olivaceus; TFPI

Year:  2021        PMID: 33632337     DOI: 10.1186/s13567-021-00908-y

Source DB:  PubMed          Journal:  Vet Res        ISSN: 0928-4249            Impact factor:   3.683


  47 in total

1.  TFPIβ is the GPI-anchored TFPI isoform on human endothelial cells and placental microsomes.

Authors:  Thomas J Girard; Elodee Tuley; George J Broze
Journal:  Blood       Date:  2011-12-05       Impact factor: 22.113

2.  Role for the Kunitz-3 domain of tissue factor pathway inhibitor-alpha in cell surface binding.

Authors:  Orlando Piro; George J Broze
Journal:  Circulation       Date:  2004-11-22       Impact factor: 29.690

3.  Tissue factor/tissue factor pathway inhibitor.

Authors:  J Fareed; J L Francis
Journal:  Blood Coagul Fibrinolysis       Date:  1995-06       Impact factor: 1.276

Review 4.  Tissue factor pathway inhibitor.

Authors:  M Camici; A Sagripanti
Journal:  Minerva Med       Date:  1999 Jan-Feb       Impact factor: 4.806

5.  Regulation of ProMMP-1 and ProMMP-3 activation by tissue factor pathway inhibitor-2/matrix-associated serine protease inhibitor.

Authors:  C N Rao; S Mohanam; A Puppala; J S Rao
Journal:  Biochem Biophys Res Commun       Date:  1999-02-05       Impact factor: 3.575

Review 6.  Tissue factor pathway inhibitor: structure, biology and involvement in disease.

Authors:  Bashir A Lwaleed; Paul S Bass
Journal:  J Pathol       Date:  2006-02       Impact factor: 7.996

7.  cDNA cloning and mRNA expression of a serine proteinase inhibitor secreted by cancer cells: identification as placental protein 5 and tissue factor pathway inhibitor-2.

Authors:  Y Miyagi; N Koshikawa; H Yasumitsu; E Miyagi; F Hirahara; I Aoki; K Misugi; M Umeda; K Miyazaki
Journal:  J Biochem       Date:  1994-11       Impact factor: 3.387

8.  Role of tissue factor and protease-activated receptors in a mouse model of endotoxemia.

Authors:  Rafal Pawlinski; Brian Pedersen; Gernot Schabbauer; Michael Tencati; Todd Holscher; William Boisvert; Patricia Andrade-Gordon; Rolf Dario Frank; Nigel Mackman
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

9.  Molecular cloning, expression, and partial characterization of a second human tissue-factor-pathway inhibitor.

Authors:  C A Sprecher; W Kisiel; S Mathewes; D C Foster
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

10.  Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor.

Authors:  T J Girard; L A Warren; W F Novotny; K M Likert; S G Brown; J P Miletich; G J Broze
Journal:  Nature       Date:  1989-04-06       Impact factor: 49.962

View more
  2 in total

1.  Antimicrobial and Immunoregulatory Activities of TS40, a Derived Peptide of a TFPI-2 Homologue from Black Rockfish (Sebastes schlegelii).

Authors:  Hongmei Liu; Guanghua Wang; Dongfang Hao; Changbiao Wang; Min Zhang
Journal:  Mar Drugs       Date:  2022-05-26       Impact factor: 6.085

Review 2.  Physiological and Clinical Aspects of Bioactive Peptides from Marine Animals.

Authors:  Sukwasa Chakniramol; Andreas Wierschem; Man-Gi Cho; Khawaja Muhammad Imran Bashir
Journal:  Antioxidants (Basel)       Date:  2022-05-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.